Maravai Lifesciences Holdings (MRVI) Gains from Investment Securities (2022 - 2025)
Maravai Lifesciences Holdings' (MRVI) quarterly Gains from Investment Securities came in at $140000.0 in Q2 2025, up 111.72% year-on-year from $66126.5 in Q2 2024, and up 122.22% quarter-over-quarter from -$630000.0 in Q4 2024.
Maravai Lifesciences Holdings (MRVI) Gains from Investment Securities (2022 - 2025) Analysis & Trends
Maravai Lifesciences Holdings' Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $140000.0 for Q2 2025.
- On a quarterly basis, Gains from Investment Securities rose 111.72% year-over-year to $140000.0 in Q2 2025; TTM through Jun 2025 was -$1.9 million, a 58.42% increase from a year earlier, with the FY2024 full-year figure at -$2.0 million, up 39.04% from the prior year.
- Gains from Investment Securities climbed to $140000.0 in Q2 2025 per MRVI's latest filing, from -$630000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.4 million in Q3 2023 and bottomed at -$7.8 million in Q1 2022.
- The 4-year median for Gains from Investment Securities is -$1.8 million (2023), against an average of -$2.6 million.
- Across the five-year window, Gains from Investment Securities sank 107.46% in 2024 and surged 111.72% in 2025, its largest moves.
- Year by year, Gains from Investment Securities stood at -$7.8 million in 2022, then jumped by 56.99% to -$3.4 million in 2023, then surged by 81.22% to -$630000.0 in 2024, then jumped by 122.22% to $140000.0 in 2025.
- Per Business Quant, the three latest MRVI Gains from Investment Securities figures stand at $140000.0 (Q2 2025), -$630000.0 (Q4 2024), and -$178000.0 (Q3 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Maravai Lifesciences Holdings | 978.13 Mn | 812.20 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Dec 31, 2024 | -630,000.00 |
| Dec 31, 2024 | -630,000.00 |
| Sep 30, 2024 | -178,000.00 |
| Sep 30, 2024 | -178,000.00 |
| Jun 30, 2024 | -1.20 Mn |
| Jun 30, 2024 | -1.20 Mn |
| Dec 31, 2023 | -3.36 Mn |
| Dec 31, 2023 | -3.36 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | -2.32 Mn |
| Jun 30, 2023 | -2.32 Mn |
| Mar 31, 2023 | -5.29 Mn |
| Mar 31, 2023 | -5.29 Mn |
| Jun 30, 2022 | -7.80 Mn |
| Jun 30, 2022 | -7.80 Mn |
| Mar 31, 2022 | -7.80 Mn |
| Mar 31, 2022 | -7.80 Mn |